Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 2017

View Archived Issues

Improved respiratory pathology associated to Pompe disease with the new vector AAV-B1-GAA

Complement factor B targeted with IONIS-FB-LRX for age-related macular degeneration

Otsuka and Teva enter licensing agreement for fremanezumab in Japan

Phase III NEURO-TTR study of inotersen meets both primary endpoints

Phase I results for tetravalent dengue vaccine TV-003 in flavivirus-experienced subjects

Novel nickel catalyst transforms unrefined hydrocarbons and carbon dioxide into valuable fatty acids

FDA accepts Aerie Pharmaceuticals' NDA for Rhopressa

Biogen acquires Cirara from Remedy Pharmaceuticals

Cytokinetics' CK-2127107 named FDA orphan drug for SMA

Quadruplex sgRNAs/saCas9 AAV gene therapy results in successful HIV-1 provirus excision in vivo

FDA grants breakthrough therapy designation to entrectinib

Imara's IMR-687 awarded FDA rare pediatric disease designation

Immunomic Therapeutics and Annias enter license agreement for cancer immunotherapy technology

Development of cell-mediated gene therapy Invossa updated at ASCGT

New prophylactic vaccine against influenza A and B viruses

Takeda splits off part of its pharmaceutical research businesses to new company

Improved polymerase-1 inhibitor RAM-589.555 synthesized for multiple sclerosis treatment

Advaxis reports data from phase I study of axalimogene filolisbac

Enterin initiates phase I/IIa study of synthetic squalamine derivative for Parkinson's disease

Glenmark Pharmaceuticals cleared to begin phase I study of GBR-1342

Boehringer Ingelheim plans phase II trial for PXS-4728A in second indication

VV-2003, an ORAI1 calcium channel inhibitor for the treatment of colitis

BiomX raises funds to support development of mircrobiome therapeutics

Formation Biologics begins phase I/IIa trial of AVID-100

Amicus Therapeutics reports results from phase I/II study in Pompe disease

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...